Frost & Sullivan Names Yoh-Chie Lu of Biosensors International Cardiovascular CEO of the Year.Business Editors/Health/Medical Writers SAN FRANCISCO--(BUSINESS WIRE)--March 25, 2004 Frost & Sullivan announced today that it has recognized Yoh-Chie Lu of Biosensors International Biosensors International Group (SGX: B20) is a medical device company that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. with the 2004 Cardiovascular CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of the Year Award, presented at last night's Global Excellence in Medical Devices Awards Banquet in San Francisco, Calif. Spearheaded by Mr. Lu, Biosensors has expanded not only its revenue and profits, but also its global presence. Mr. Lu's pioneering efforts have established Biosensors as a name to reckon with to settle accounts or claims with; - used literally or figuratively. to include as a factor in one's plans or calculations; to anticipate. to deal with; to handle; as, I have to reckon with raising three children as well as doing my job s>. See also: Reckon Reckon Reckon in the cardiovascular medical devices industry. Among his leadership initiatives, Mr. Lu has introduced dramatic changes in the corporate culture of the diversified international medical products and devices company, focusing the attention of his associates' worldwide-specific, carefully calibrated cal·i·brate tr.v. cal·i·brat·ed, cal·i·brat·ing, cal·i·brates 1. To check, adjust, or determine by comparison with a standard (the graduations of a quantitative measuring instrument): performance goals. He has identified innovative products, orchestrated operational excellence, cultivated teamwork, and emphasized a customer-centric approach as critical to the growth of the company. He has also initiated key strategic alliances, most significantly with medical device giants Guidant and Terumo, both in 2003, for the development and marketing of innovative drug-eluting stents. This step has brought tremendous benefits not only to company stakeholders but also to the medical community's quest for drugs and devices that now enable life-saving and life-enhancing treatment of previously inoperable inoperable /in·op·er·a·ble/ (in-op´er-ah-b'l) not susceptible to treatment by surgery. in·op·er·a·ble adj. Unsuitable for a surgical procedure. cardiovascular patients. Under Mr. Lu's leadership, Biosensors has achieved a number of important technological breakthroughs, such as the development of the S-Stent. This revolutionary device is now being used extensively in hospitals and clinics in a number of countries to restore and maintain normal blood flow in coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. patients. Biosensors' S-Stent is implanted in clogged vessels and arteries to restore normal blood flow. A unique aspect of this device is that it was developed specifically for implantation in the relatively small, tortuous vessels typical of the Asian physique. The Company's R&D, sales and manufacturing presence in Singapore gave Biosensors a strong advantage in developing the S-Stent. However, Mr. Lu's technological vision for the product also encompassed its potential to be used in the Western world as well. Significant global alliances with companies such as Guidant and Terumo have been greatly instrumental in making this possible. "Biosensors International, guided by Yoh-Chie Lu's innovative growth strategies, is set to become a major market participant and a well-respected name among end users in the future," said Frost & Sullivan industry analyst Amit Bohora. "Mr. Lu's initiatives have yielded aggressive returns for his company's stakeholders. His focus on research and development, while continuing to serve the specific needs of end users in established markets worldwide, is expected to result in increased revenues and profits in the coming years." "It is indeed a gratifying grat·i·fy tr.v. grat·i·fied, grat·i·fy·ing, grat·i·fies 1. To please or satisfy: His achievement gratified his father. See Synonyms at please. 2. honor to receive this award," said Yoh-Chie Lu. "I would like to thank the Frost & Sullivan organization for evaluating our exciting progress over the last few years and crediting my part in it. Being rewarded for doing what you love to do is more fulfilling than I would ever hope for, and I am proud to share this award with all the hard-working and innovative members of the Biosensors International team. It is their efforts that are truly being recognized here." Frost & Sullivan presents CEO of the Year Award to the CEO whose outstanding leadership, vision, and integrity have had a profound influence on a company's performance and direction. The award commends the recipient for pursuing unique organizational restructuring or reengineering strategies that have positively impacted the company's market position. Held annually, the Frost & Sullivan awards banquet recognizes world-class companies for outstanding performance and achievements in the medical devices industry. About Biosensors International Biosensors focuses its research in the fields of new drug discovery, stent design, and local drug delivery coating development for interventional cardiology interventional cardiology Cardiology The subspecialty of cardiology dedicated to the diagnosis, medical and mechanical therapy, pre- and post-procedure management of adult patients with acute and chronic forms of cardiovascular disease amenable to catheter-based markets worldwide. Biosensors International is a subsidiary of Sun Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Limited, and seeks to become a leading company specializing in cardiovascular technology. Its manufacturing facilities are certified by world authorities such as the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. , TGA See TARGA. TGA - Targa Graphics Adaptor , ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. , and CE Mark. For more information, please visit www.biosensorsintl.com. For more information, please visit http://www.biosensors.com.sg. U.S. Contact: Biosensors International USA, 949-553-8300 InvestorInfo@Biosensors-usa.com Media Relations contacts: Sean Collins, CCG CCG Chicago CCG Collectible Card Game CCG Canadian Coast Guard CCG Country Commercial Guide CCG Children's Cancer Group CCG Commission Canadienne des Grains (Canadian Grain Commission) , 818-789-0100 or 310-497-9205; or Valerie Bent, 702-270-9696. About Frost & Sullivan Founded in 1961, Frost & Sullivan is recognized as a global leader in growth consulting. Frost & Sullivan Awards are presented to companies that demonstrate excellence in their industry, commending the diligence, commitment, and innovative business strategies required to advance in the global marketplace. Frost & Sullivan rigorously analyzes specific criteria to determine award recipients in a vast variety of market industries and landscapes. For further information, visit www.frost.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion